The DOI matches its Crossref record.
α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects
Abstract
With α‐glucosidase inhibitors generally improved metabolic control is achieved in NIDDM patients regardless of whether acarbose is administered in addition to other oral anti‐diabetic agents or to diet alone. The most significant finding is the reduction of postprandial blood glucose concentrations. Long‐term studies show a decrease in glycosylated haemoglobin and often also in fasting blood glucose levels. Placebo‐controlled studies have proven that postprandial insulin concentrations are decreased under acarbose treatment while fasting plasma insulin is usually unchanged. The major side‐effects of acarbose treatment involve the gastrointestinal system and include flatulence, abdominal discomfort and diarrhoea. Symptoms diminish with treatment time and are less severe when the treatment is started with low doses. Acarbose should usually be initiated as a 50 mg dose immediately before each major carbohydrate containing meal. Monotherapy with acarbose does not cause hypoglycaemia, however, hypoglycaemia may occur with combination of sulphonylurea or insulin treatment by the well‐known reasons. In this case hypoglycaemia has to be treated by taking glucose.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Health benefits of finger millet (Eleusine coracana L.) polyphenols and dietary fiber: a review
Devi, P. B., Vijayabharathi, R., Sathyabama, S., Malleshi, N. G., & Priyadarisini, V. B. (2014) · Journal of Food Science and Technology · doi:10.1007/s13197-011-0584-9 · Cited by 860
Tannins: Current knowledge of food sources, intake, bioavailability and biological effects
Serrano, J., Puupponen‐Pimiä, R., Dauer, A., Aura, A., & Saura‐Calixto, F. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900039 · Cited by 810
Efficacy and Metabolic Effects of Metformin and Troglitazone in Type II Diabetes Mellitus
Inzucchi, S. E., Maggs, D. G., Spollett, G. R., Page, S. L., Rife, F. S., Walton, V., & Shulman, G. I. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803263381303 · Cited by 794
Different Polyphenolic Components of Soft Fruits Inhibit α-Amylase and α-Glucosidase
McDougall, G. J., Shpiro, F., Dobson, P., Smith, P., Blake, A., & Stewart, D. (2005) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf0489926 · Cited by 674
Inhibitory effect of pine extract on α-glucosidase activity and postprandial hyperglycemia
Kim, Y.-M., Jeong, Y.-K., Wang, M.-H., Lee, W.-Y., & Rhee, H.-I. (2005) · Nutrition · doi:10.1016/j.nut.2004.10.014 · Cited by 531
Metadata
- Authors
- TOELLER, M.
- Venue
- European Journal of Clinical Investigation
- Publisher
- Wiley
- Published
- 1994-08
- Volume
- 24
- Issue
- S3
- Pages
- 31-35
- ISSN
- 0014-2972 (ISSN-L)
- 1365-2362
- OpenAlex
- W1998869732
- Cited by
- 213
- References
- 0
- FWCI
- 2.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. https://app.cochat.ai/papers/10.1111/j.1365-2362.1994.tb02253.x
- The paper
- TOELLER, M. (1994). α‐Glucosidase inhibitors in diabetes: efficacy in NIDDM subjects. European Journal of Clinical Investigation. https://doi.org/10.1111/j.1365-2362.1994.tb02253.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.